Bio Path Holdings Inc (BPTH)

[wordlender]

Good news could come any day, and if that happens the stock could go up substantially. That's why we don't sell and definitely don't short-sell.

Unless you are a professional trader, trying to time the market is too dangerous. You have to watch it all the time and need enough experience to buy and sell on information and instinct. I don't have time to watch this all the time. I have a stock app on my phone that gives me all the quotes I need. I check it daily, but that takes one minute a day. I like this message board, so I spend bit more time here.

We should buy and hold BPTH. You don't know when they will announce a partnership or interim phase 2 results. Either piece of news could send the stock soaring.

Each one of their drug candidates have multi-billion dollar revenue potential. Let's say in five years they have $5 billion in revenue (which is possible with prexigerbersen alone). Give them a 1x revenue valuation with 200 million shares (this assumes more stock offerings, excluding reverse split). That's $25 per share. Ionis pharma is valued at 14x revenue (approximately). I will wait for the home run rather than try to dig out a single on a bunt.

Still long.